Differential Effects of Angiotensin II Versus Endothelin-1 Inhibitions in Hypertrophic Left Ventricular Myocardium During Transition to Heart Failure | Zendy

Yoshitaka Iwanaga | Zendy; Yasuki Kihara | Zendy; Koichi Inagaki | Zendy; Yoko Onozawa | Zendy; Takeshi Yoneda | Zendy; Kazuaki Kataoka | Zendy; Shigetake Sasayama | Zendy

Open Access

Differential Effects of Angiotensin II Versus Endothelin-1 Inhibitions in Hypertrophic Left Ventricular Myocardium During Transition to Heart Failure

Author(s) -

Yoshitaka Iwanaga,

Yasuki Kihara,

Koichi Inagaki,

Yoko Onozawa,

Takeshi Yoneda,

Kazuaki Kataoka,

Shigetake Sasayama

Publication year - 2001

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/hc3101.092201

Subject(s) - medicine , heart failure , cardiology , bosentan , angiotensin ii , endothelin receptor , muscle hypertrophy , endothelin 1 , endocrinology , ace inhibitor , left ventricular hypertrophy , angiotensin ii receptor type 1 , losartan , blood pressure , angiotensin converting enzyme , receptor

In view of their mutual crosstalk, the roles of angiotensin II (Ang II) and endothelin-1 (ET-1) in the myocardium are assumed to be synergistic and supplemental.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research